Location: Home
  • search
  • go
  • Relate News
  • 7/1/2022Recent Executive Moves
  • 7/1/2022Solasia to Slash 65% of Workforce in China as It Transfers Core Distri...
  • 6/29/2022WuXi STA Opens Another High-Potency API Plant In Changzhou
  • 6/29/2022NMPA Issues the Implementation Plans for Manufacture by Hong Kong and ...
  • 6/29/2022Nature: Unleashing the Power of Big Data to Guide Precision Medicine i...
  • 6/28/2022NMPA Issues Notice to Further Strengthen Services to Foreign-Invested ...
  • 6/28/2022BioLineRx and GenFleet Agree to Further Develop Motixafortide in PDAC...
  • 6/27/2022Snapshot of Patient Expenditures of Level II and Above Public Hospital...
  • 6/27/2022Amgen Strikes Outliciensing Deal with Fosun for Otezla and Parsabiv in...
  • 6/27/2022Antengene Enters Clinical Partnership with BeiGene to Evaluate Selinex...
  • 6/24/2022At ASCO 2022, Chinese Biotech Firms Deliver Rosy Data On PD-(L)1, Cell...
  • 6/23/2022Sino Biopharmaceutical to Acquire F-Star Therapeutics for $161M
  • 6/23/2022NMPA Announces Package Insert Revision of Glucosamine Formulations
  • 6/23/2022Deloitte Maps Out Four Likely Scenarios for China's Health Ecosystem i...
  • 6/22/2022China's Mental-health Crisis Is Getting Worse (Economist)
  • 6/21/2022China's May Fundraising Indicates Interest in Early-stage Biotech
  • 6/21/2022Xuanzhu Biopharma Out-licenses Greater China Rights of Two Anti-infect...
  • 6/21/2022Innovent and Lilly Jointly Announce Chinese Approval of TYVYT Combo wi...
  • 6/21/2022JPO Issues Bidding Documents for the 7th Round of Volume-Based Procure...
  • 6/21/2022AstraZeneca to Open New Regional Headquarters in Qingdao
  • 6/18/2022Understanding China's Internet Healthcare and Opportunities for Invest...
  • 6/16/2022Pharma Downplays Challenges, Seeing Innovation Instead (Biospace)
  • 6/16/2022May Approvals Spotlight the Rise of Pediatric Drugs under Policy Suppo...
  • 6/16/2022WuXi ATU and Wugen Form Manufacturing Partnership for Novel Cell Cance...
  • 6/15/2022Data Snapshot: Competitive Landscape of Chinese Biosimilars
  • 6/15/2022NMPA Holds Forum to Hear Feedbacks from Pharma MNCs
  • 6/15/2022NHSA Releases the Draft Working Plan and the Application Guide for Adj...
  • 6/14/2022IQVIA: Chinese Retail Pharmacy Sales Down 1.2% in Q1/2022
  • 6/14/2022NHSA Publishes 2021 National Basic Medical Insurance Sector Developmen...
  • 6/14/2022Pharma Giants Turn to Incubators to Tap Chinese Innovation and Hatch S...
  • Page:75/367 Total number of articles:10986: [First][<<] [73] [74] [75] [76] [77] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group